19.96

1.82% -0.37

After Hours: 19.96

CARGO Therapeutics Inc (CRGX)

Overview News Price History Financials Discussions Forecast

CARGO Therapeutics Inc stock is currently priced at $19.96, with a 24-hour trading volume of 151.84K. It has seen a -1.82% decreased in the last 24 hours and a -7.12% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $20.86 pivot point. If it approaches the $19.60 support level, significant changes may occur.

Previous Close:

$20.33

Open:

$20.3

24h Volume:

151.84K

Market Cap:

$785.80M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+4.72%

1M Performance:

-7.12%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1D Range:

$19.24

$21.17

52W Range:

$13.14

$33.92

CARGO Therapeutics Inc Stock (CRGX) Company Profile

Name

CARGO Therapeutics Inc

Sector

Healthcare (1215)

Industry

Biotechnology (700)

Phone

650-379-6143

Address

1900 Alameda De Las Pulgas, Suite 350, San Mateo

Employee

Twitter

Next Earnings Date

Latest SEC Filings

CRGX's Discussions on Twitter

CARGO Therapeutics Inc Stock (CRGX) Latest News

CARGO Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire Inc.

Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga

Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday

Benzinga

CARGO Therapeutics Inc Stock (CRGX) Financials Data

There is no financial data for CARGO Therapeutics Inc (CRGX). Check out other stocks for more information.

CARGO Therapeutics Inc Stock (CRGX) Insider Trading

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total
Third Rock Ventures V, L.P.	10% Owner	Nov 14 '23	Buy	15.00	1,333,333	19,999,995	1,807,119
PERCEPTIVE ADVISORS LLC	Former 10% Owner	Nov 14 '23	Buy	15.00	666,666	9,999,990	2,912,835
Samsara BioCapital GP, LLC	10% Owner	Nov 14 '23	Buy	15.00	666,666	9,999,990	4,121,689

CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.